Conditioning regimen using busulfan plus melphalan in hematopoietic stem cell transplantation: can this conditioning regimen be used in autologous or allogeneic transplantation for acute leukemia?

Conditioning regimen using busulfan plus melphalan in hematopoietic stem cell transplantation: can this conditioning regimen be used in autologous or allogeneic transplantation for acute leukemia?

Bibliographic Details
Main Authors:	Roberto M Lemoli, Alessandra D'Addio
Format:	Article
Language:	English
Published:	Elsevier 2011-06-01
Series:	Revista Brasileira de Hematologia e Hemoterapia
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842011000300002

Similar Items

Busulfan and melphalan as conditioning regimen for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia in first complete remission
by: Nadjanara Dorna Bueno, et al.
Published: (2011-06-01)

Pharmacokinetic targeting of intravenous busulfan reduces conditioning regimen related toxicity following allogeneic hematopoietic cell transplantation for acute myelogenous leukemia
by: Nishihori Taiga, et al.
Published: (2010-10-01)

Busulfan plus fludarabine as a myeloablative conditioning regimen compared with busulfan plus cyclophosphamide for acute myeloid leukemia in first complete remission undergoing allogeneic hematopoietic stem cell transplantation: a prospective and multicenter study
by: Liu Hui, et al.
Published: (2013-02-01)

Conditioning Regimens in Allogeneic Hematopoietic Stem Cell Transplantation
by: Betul Tavil
Published: (2014-02-01)

Busulfan plus melphalan melphalan alone conditioning regimen after bortezomib based triplet induction chemotherapy for patients with newly diagnosed multiple myeloma
by: Songyi Park, et al.
Published: (2021-05-01)

Comparative effectiveness of busulfan/cyclophosphamide versus busulfan/fludarabine myeloablative conditioning for allogeneic hematopoietic cell transplantation in acute myeloid leukemia and myelodysplastic syndrome
by: Sagar S. Patel, et al.
Published: (2020-09-01)

Cyclophosphamide plus total body irradiation compared with busulfan plus cyclophosphamide as a conditioning regimen prior to hematopoietic stem cell transplantation in patients with leukemia: a systematic review and meta-analysis
by: Tejpal Gupta, et al.
Published: (2011-01-01)

The association of conditioning regimen with cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation
by: Masoud Mardani, et al.
Published: (2020-12-01)

Outcome of allogeneic stem cell transplantation with a conditioning regimen of busulfan, cyclophosphamide and low-dose etoposide for children with myelodysplastic syndrome
by: Amal Al-Seraihy, et al.
Published: (2011-07-01)

The Efficacy and Safety of Busulfan-Etoposide-Melphalan Regimen in Autologous Stem Cell Transplantation in Relapsed/ Refractory Hodgkin and Non-Hodgkin Lymphoma Patients: “A Single-Center Experience”
by: Ali Eser, et al.
Published: (2021-05-01)

Bussulfano e melfalano como regime de condicionamento para o transplante autogênico de células-tronco hematopoéticas na leucemia mielóide aguda em primeira remissão completa Busulfan and melphalan as conditioning regimen for autologous hematopoietic stem cell transplantation in acute myeloid leukemia in first complete remission
by: Nadjanara D. Bueno, et al.
Published: (2008-10-01)

Allogeneic hematopoietic stem cells transplantation with reduced intensity conditioning regimen in children and adolescents with unfavorable forms of acute lymphoblastic leukemia
by: E. V. Semenova, et al.
Published: (2014-07-01)

Allogeneic hematopoietic stem cells transplantation with reduced intensity conditioning regimen in children and adolescents with unfavorable forms of acute lymphoblastic leukemia
by: E. V. Semenova, et al.
Published: (2014-07-01)

Experience with the Use of Thio/Mel Conditioning Regimen Prior to Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma
by: SV Gritsaev, et al.
Published: (2019-05-01)

EAM conditioning regimen followed by autologous hematopoietic Stem Cell Transplantation for relapsed, refractory and high risk lymphomas
by: Mohamed BEKADJA, et al.
Published: (2014-08-01)

Reduced Risk of Sinusoidal Obstruction Syndrome of the Liver after Busulfan‐Cyclophosphamide Conditioning Prior to Allogeneic Hematopoietic Stem Cell Transplantation
by: Ibrahim El‐Serafi, et al.
Published: (2020-03-01)

Melphalan Culprit or Confounder in Acute Encephalopathy during Autologous Hematopoietic Stem Cell Transplantation?
by: Diógenes Alayón-Laguer, et al.
Published: (2012-01-01)

Irradiation free conditioning regimen is associated with high relapse rate in Egyptian patients with acute lymphoblastic leukemia following allogeneic hematopoietic stem cell transplantation
by: Mona Mahrous Abdelaty, et al.
Published: (2020-06-01)

Use of Busulfan to Condition Mice for Bone Marrow Transplantation
by: Encarnacion Montecino-Rodriguez, et al.
Published: (2020-12-01)

A retrospective comparison of cyclophosphamide plus antithymocyte globulin with cyclophosphamide plus busulfan as the conditioning regimen for severe aplastic anemia
by: L.V.M. Ommati, et al.
Published: (2009-03-01)

Long-Term Outcomes of Treosulfan- vs. Busulfan-Based Conditioning Regimen for Patients With Myelodysplastic Syndrome and Acute Myeloid Leukemia Before Hematopoietic Cell Transplantation: A Systematic Review and Meta-Analysis
by: Sheng Zhu, et al.
Published: (2020-12-01)

A Comparison of Allogeneic and Autologous Hematopoietic Stem Cell Transplantation for Acute Myeloblastic Leukemia
by: Ardeshir Ghavamzadeh, et al.
Published: (2009-03-01)

A Comparison of Allogeneic and Autologous Hematopoietic Stem Cell Transplantation for Acute Myeloblastic Leukemia
by: Farnaz Khatami, et al.
Published: (2009-01-01)

Gonadal status following bone marrow transplantation with low dose busulfan-cyclophosphamide regimen
by: Mohsen Khosh niat Nikoo, et al.
Published: (2006-02-01)

Safety and Efficacy of BeEAC as a Conditioning Regimen Prior to Autologous Hematopoietic Stem Cell Transplantation in Relapsed/Refractory Lymphomas
by: VO Sarzhevskii, et al.
Published: (2019-03-01)

SHIPi Enhances Autologous and Allogeneic Hematopoietic Stem Cell Transplantation
by: Sandra Fernandes, et al.
Published: (2015-03-01)

Endocrinopathies after Allogeneic and Autologous Transplantation of Hematopoietic Stem Cells
by: Francesco Orio, et al.
Published: (2014-01-01)

Evaluation of Reversed Administration Order of Busulfan (BU) and Cyclophosphamide (CY) as Conditioning on Liver Toxicity in Allogenic Hematopoietic Stem Cell Transplantation (ALL-HSCT)
by: Mani Ramzi, et al.
Published: (2020-07-01)

The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update
by: Xiao-hui Zhang, et al.
Published: (2021-09-01)

Current Status and Perspectives of Irradiation-Based Conditioning Regimens for Patients with Acute Leukemia Undergoing Hematopoietic Stem Cell Transplantation
by: Rashmika R. Potdar, et al.
Published: (2019-03-01)

Combining Mobilizing Agents with Busulfan to Reduce Chemotherapy-Based Conditioning for Hematopoietic Stem Cell Transplantation
by: Laura Garcia-Perez, et al.
Published: (2021-04-01)

NRF2 -617 C/A Polymorphism Impacts Proinflammatory Cytokine Levels, Survival, and Transplant-Related Mortality After Hematopoietic Stem Cell Transplantation in Adult Patients Receiving Busulfan-Based Conditioning Regimens
by: Jingjing Huang, et al.
Published: (2020-12-01)

l-asparaginase-based regimens followed by allogeneic hematopoietic stem cell transplantation improve outcomes in aggressive natural killer cell leukemia
by: Ki Sun Jung, et al.
Published: (2016-04-01)

Modified conditioning regimen with idarubicin followed by autologous hematopoietic stem cell transplantation for invasive B-cell non-Hodgkin’s lymphoma patients
by: Chen Tian, et al.
Published: (2021-02-01)

The Confirmation of Safety for the Intensified Conditioning Regimens: A Retrospective Study of Allogeneic Hematopoietic Stem Cell Transplantation for Non-Remission Hematological Malignant Diseases
by: Shuro Yoshida, et al.
Published: (2018-04-01)

The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China—recommendations from the Chinese Society of Hematology
by: Lanping Xu, et al.
Published: (2018-03-01)

Impact of in vivo T cell depletion in HLA-identical allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission conditioned with a fludarabine iv-busulfan myeloablative regimen: a report from the EBMT Acute Leukemia Working Party
by: Marie Thérèse Rubio, et al.
Published: (2017-01-01)

Novel conditioning regimens for bone marrow transplantation
by: Shi M, et al.
Published: (2013-01-01)

Long-term outcomes of innovator versus generic melphalan formulation in autologous hematopoietic cell transplantation for multiple myeloma
by: Deepesh P. Lad, et al.
Published: (2021-06-01)

Choice of Donor Source and Conditioning Regimen for Hematopoietic Stem Cell Transplantation in Sickle Cell Disease
by: Emily Limerick, et al.
Published: (2019-11-01)

Cannot write session to /tmp/vufind_sessions/sess_7225ckuo52jv6rihnrgsn42mpb